NanoVibronix Receives Wound Healing Indications in Europe for its PainShield(TM) Device

NESHER, Israel, April 21 /PRNewswire/ — NanoVibronix, a medical device
company specializing in applications that implement surface ultrasound waves,
announced that its novel device has received CE approval in Europe for
additional claims of wound healing. PainShield is the first hands-free,
patch-based device that uses surface ultrasound waves for therapeutic
treatment of wounds. The innovative PainShield consists of a disposable patch
connected to a portable driver. PainShield for wound therapy will be
introduced at the upcoming European Wound Management Association (EWMA)
conference in Helsinki, Finland on May 20 – 22, 2009.

“My experience with PainShield has shown that it is one of the most
striking therapeutic modalities in chronic wound care. PainShield implements
the benefits of ultrasound to enhance the therapeutic processes required for
chronic wound healing, and has shown to do that repeatedly both in the
clinical and home setting. “, stated Dr. Jonathan Rosenblum, Director,
Diabetic Foot Service, Shaare Zedek Medical Center, Jerusalem, Israel. Dr.
Rosenblum will be presenting his experience with PainShield for chronic
wounds at the International Conference of Dermatology (ICD), Prague, Czech
Republic on May 20 – 24, 2009.

Dr. Leon Gilad, Chief of Wound Care at Hadassah University Medical
Center, Jerusalem, Israel, said, “The beneficial properties of low frequency,
low intensity ultrasound in a compact, convenient patch allows for a whole
new dimension in wound therapy. The ability to place the PainShield patch on
healthy skin adjacent to the wound allows the ongoing wound care to continue
uninterrupted, while therapeutic ultrasound is provided simultaneously to the
wound site. In addition to the wound healing benefits of the PainShield, we
have seen a dramatic diminishing of wound pain when pain was present.”

NanoVibronix CEO, Dr. Harold Jacob, added, “PainShield, which implements
our unique low frequency ultrasound platform, has been shown in a number of
independent studies to have powerful tissue regenerative properties.
NanoVibronix has created a platform that allows physicians to easily apply
therapeutic ultrasound to assist in wound healing without interfering with
any of the other modalities that are being utilized. Our simple-to-use,
portable patch-based device can treat wounds in the hospital or at home,
allowing patients to continue with their daily activities.”

About the Company

NanoVibronix, located in Nesher Israel, develops medical devices that
implement its proprietary therapeutic ultrasound technology. The innovative
portable PainShield device for treatment of pain gained FDA clearance in
October 2008. The Company is planning to launch the product in the USA during
the second half of 2009. The company has also developed a unique line of
catheter-based disposable ultrasound devices designed to treat catheter
associated injury including pain, discomfort and biofilm formation. The first
two products in this family are the UroShield(TM) for indwelling urinary
catheters and the NG-Shield(TM) for indwelling Nasogastric tubes.

    http://www.nanovibronix.com

    For more information, please contact:

    Amir Rippel, VP Marketing
    NanoVibronix Ltd.
    Tel: +972-4-820-0581
    Fax: +972-4-820-2794
    info@nanovibronix.com

SOURCE NanoVibronix Ltd.